Claire Marie Porter is a reporter with The Cancer Letter. She joined the publication in 2024.

Before joining The Cancer Letter, Claire was a freelance health and science journalist with bylines in The Atlantic, Scientific American, The Washington Post, Undark Magazine, Popular Science, WIRED among other publications. She graduated with an M.S. in Journalism from Columbia University in 2020, where she received honors for her thesis "The Deadly Itch" on Intrahepatic Cholestasis of pregnancy.

She was a 2020 Society of Environmental Journalists grant recipient, and completed internships with Next City and National Public Radio.

She graduated from Temple University with a Bachelor’s degree in English in 2013.
Latest Stories
In weekly vigils, current and former NIH staff grieve the impact of Trump cuts The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater
Free
Source: NIH vigil organizerSince early May, a group of current and former NIH employees have gathered every Saturday at the Medical Center Metro station in Bethesda, MD, to mourn what they describe as the loss of scientific progress under the Trump administration.
Cancer Policy
The U.S. House of Representatives Thursday passed President Trump’s “One Big Beautiful Bill,” a sweeping legislation that makes the biggest cuts to Medicaid since the program began in the 1960s.
Cancer Policy
Researchers funded by NIH will now be required to make their scientific papers available to read for free as soon as they are published in a peer-reviewed journal. 
NIDA director Volkow gets candid on addiction in Bhattacharya’s podcast
Cancer Policy
NIH Director Jay Bhattacharya has started his own podcast called “The Director’s Desk,” where, according to the description on YouTube, he plans to host weekly conversations on scientific careers, leadership, and innovation at NIH.
At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies Rep. Lori Trahan: “People are going to die”
Capitol Hill
Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.
Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA
Cancer Policy
Jacqueline Corrigan-Curay, the acting director of the Center for Drug Evaluation and Research wrote in an email to colleagues that she will be retiring from the agency in July.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login